Predicting cancer-related mycobiome aspects in gastrointestinal cancers: a systematic review by György Szklenarik, Peter Kiraly, Gabor Szegvari, David Dora, Zoltan Lohinai

Get full text

Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence by Csenge Somodi, David Dora, Mátyás Horváth, Gabor Szegvari, Zoltan Lohinai

Get full text

Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 s... by David Dora, Balazs Ligeti, Tamas Kovacs, Peter Revisnyei, Gabriella Galffy, Edit Dulka, Dániel Krizsán, Regina Kalcsevszki, Zsolt Megyesfalvi, Balazs Dome, Glen J. Weiss, Zoltan Lohinai

Get full text

Host and bacterial urine proteomics might predict treatment outcomes for immunotherapy in advanced non-small cell lung cancer patients by David Dora, Peter Revisnyei, Peter Revisnyei, Alija Pasic, Gabriella Galffy, Edit Dulka, Anna Mihucz, Brigitta Roskó, Sara Szincsak, Anton Iliuk, Glen J. Weiss, Zoltan Lohinai, Zoltan Lohinai

Get full text

Expression of costimulatory molecule CD70 is prognostic in small cell lung cancer by David Dora, Zsolt Megyesfalvi, Imre Vörös, Ágnes Paál, Peter Takacs, Daniela Dobos, Bence Lőrincz, Syeda Mahak Zahra Bokhari, Kenan Aloss, Gergely Pallag, Christopher Rivard, Hui Yu, Fred R. Hirsch, Anikó Görbe, Zoltán V. Varga, Zoltan Lohinai, Balazs Dome

Get full text